PRO OSTEON IMPLANT 500R RESORBABLE BONE GRAFT SUBSTITUTE— 510(k) K990131

Name: FDA 510(k) clearance K990131
Creator: U.S. Food and Drug Administration
Published: 1999-03-02

Substantially Equivalent

Interpore Cross Intl.

FDA 510(k) clearance K990131 for PRO OSTEON IMPLANT 500R RESORBABLE BONE GRAFT SUBSTITUTE, Substantially Equivalent on 1999-03-02. Applicant: Interpore Cross Intl.. Device class: 2.

Clearance details

Applicant: Interpore Cross Intl.
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 1999-01-14
Decision date: 1999-03-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Interpore Cross Intl.

view all

K050861 — PEEK CAS2005-05-27
K031399 — INTERGRO DBM2005-02-18
K041407 — TITANIUM MESH IMPLANT2004-12-29
K043229 — MODIFICATION TO ALTIUS OCT SYSTEM2004-12-21
K042798 — C-TEK C-TRUN ANTERIOR CERVICAL PLATE SYSTEM2004-11-04

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.